Charisse R. Lillie - 31 Mar 2026 Form 4 Insider Report for EXELON CORP (EXC)

Reporting relationship: Director
Issuer ticker: EXC
Reported as of: 31 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Apr 2026, 15:28:23 UTC
Prior SEC filing: 02 Jan 2026
Next SEC filing: 29 Apr 2026
Source filing: View source filing
Reporting owner signature: Nevin S Boparai, attorney in fact for Charisse R Lillie

Key filing fact

Charisse R. Lillie filed Form 4 for EXELON CORP (EXC) on 01 Apr 2026.

Key facts

This page summarizes Charisse R. Lillie's Form 4 filing for EXELON CORP (EXC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Apr 2026, 15:28.

Change

Previous filing in this sequence was filed on 02 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001972789 Primary reporting owner

Lillie Charisse R

Relationship: Director
Address: 10 S DEARBORN STREET, 54TH FLOOR, CHICAGO
Signature: Nevin S Boparai, attorney in fact for Charisse R Lillie
Signature date: 01 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXC transaction

Common stock- deferred stock units

Award

Transaction value
Shares: +878
Change %: +7.5%
Price: $49.82^*
Shares after: 12,554
Date: 31 Mar 2026
Ownership: By Exelon Corp. Directors Deferred Stock Unit Plan
Footnotes: F1

EXC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,246
Date: 31 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXC transaction Derivative

Deferred phantom share equivalents

Award

Transaction value
Shares: +5
Change %: +0.13%
Price: $49.02^*
Shares after: 3,855
Date: 31 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Balance includes 98 additional shares acquired through automatic dividend reinvestment.

Footnote F2

Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.

Footnote F3

Balance includes 32 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.